Recombinant Human Thyrotropin Reduces Endothelium-Dependent Vasodilation in Patients Monitored for Differentiated Thyroid Carcinoma | Zendy

Angela Dardano | Zendy; Lorenzo Ghiadoni | Zendy; Y. Plantinga | Zendy; Nadia Caraccio | Zendy; A Bemi | Zendy; Emiliano Duranti | Zendy; Stefano Taddei | Zendy; Ele Ferrannini | Zendy; Antonio Salvetti | Zendy; Fabio Monzani | Zendy

Open Access

Recombinant Human Thyrotropin Reduces Endothelium-Dependent Vasodilation in Patients Monitored for Differentiated Thyroid Carcinoma

Author(s) -

Angela Dardano,

Lorenzo Ghiadoni,

Y. Plantinga,

Nadia Caraccio,

A Bemi,

Emiliano Duranti,

Stefano Taddei,

Ele Ferrannini,

Antonio Salvetti,

Fabio Monzani

Publication year - 2006

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-0440

Subject(s) - medicine , brachial artery , endocrinology , vasodilation , endothelium , thyroglobulin , thyroid carcinoma , oxidative stress , aldosterone , thyroid , blood pressure

We evaluated endothelial-dependent vasodilation after administration of recombinant human TSH (rhTSH) in patients monitored for differentiated thyroid carcinoma. The role of inflammation and oxidative stress was also assessed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research